Galderma launches premium Alastin skincare Line in China

CHINA – Galderma has officially launched its premium medical skincare brand Alastin in China, marking the brand’s 10th anniversary with its entry into one of the fastest-growing aesthetic skincare markets. 

The launch introduces four core Alastin products, each designed to support the skin’s natural regenerative abilities and promote recovery before and after aesthetic procedures. 

This marks the brand’s first introduction featuring its refreshed, premium packaging and reflects strong growth in key markets, including the US, Canada, and the UK.

Alan D. Widgerow, Chief Scientific Officer at Galderma, stated, “With Alastin by Galderma, we have a comprehensive perioperative solution to enhance skin recovery around aesthetic treatment and maintenance programs that bring together Galderma’s leading expertise in Dermatological Skincare and Injectable Aesthetics.“
“As the Asia-Pacific region’s beauty and aesthetics market continues to grow at a pace, we’re proud to bring Alastin to patients in China who are seeking advanced solutions to support them in their aesthetic journeys.”

This launch comes at a time when the medical aesthetics market in China is experiencing unprecedented growth, driven by shifting beauty standards, rising disposable incomes, and a surge in demand for non-invasive cosmetic procedures.

According to a report published by Data Bridge Market Research, the Chinese medical aesthetics market was valued at USD 624.89 million in 2024 and is expected to surge to USD 1.81 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 14.25% over the forecast period.

Alastin offers a comprehensive perioperative skincare solution covering all stages of the aesthetic treatment process—from preparation and recovery to at-home maintenance. 

The brand’s portfolio, backed by over 50 dermatological publications and 22 patents, is the leading peri-procedural skincare line in the US. 

The product range features key items including Regenerating Skin Nectar, HA Immerse Serum, INhance Serum, and Restorative Skin Complex, all designed to optimize skin recovery and enhance the results of aesthetic treatments. Many products are powered by Galderma’s proprietary TriHex Technology®, which boosts skin regeneration.

The brand embodies Galderma’s integrated approach, combining expertise in both dermatological skincare and injectable aesthetics to offer seamless solutions that improve patient outcomes.

This expansion marks a significant milestone for Alastin, which has achieved sustained international growth following the establishment of strong footholds in North America, Latin America, Australia, and Europe.

Galderma continues to innovate and advance dermatology by introducing effective, science-oriented skincare solutions, such as Alastin, to new global markets, thereby enhancing results throughout the aesthetic treatment continuum.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.